Cite
Can the Consideration of Societal Costs Change the Recommendation of Economic Evaluations in the Field of Rare Diseases? An Empirical Analysis
MLA
Luz María Peña-Longobardo, et al. Can the Consideration of Societal Costs Change the Recommendation of Economic Evaluations in the Field of Rare Diseases? An Empirical Analysis. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9c62eff1331a76850f93e771ea1f65f2&authtype=sso&custid=ns315887.
APA
Luz María Peña-Longobardo, Beatriz Rodríguez-Sánchez, Juan Oliva-Moreno, Isaac Aranda-Reneo, & Julio López-Bastida. (2020). Can the Consideration of Societal Costs Change the Recommendation of Economic Evaluations in the Field of Rare Diseases? An Empirical Analysis.
Chicago
Luz María Peña-Longobardo, Beatriz Rodríguez-Sánchez, Juan Oliva-Moreno, Isaac Aranda-Reneo, and Julio López-Bastida. 2020. “Can the Consideration of Societal Costs Change the Recommendation of Economic Evaluations in the Field of Rare Diseases? An Empirical Analysis,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9c62eff1331a76850f93e771ea1f65f2&authtype=sso&custid=ns315887.